NCT00045604View on ClinicalTrials.gov

Imatinib Mesylate and Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 2002

Conditions
Lung Cancer
Interventions
DRUG

cisplatin

DRUG

imatinib mesylate

DRUG

irinotecan hydrochloride

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00045604 - Imatinib Mesylate and Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter